Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization - PubMed (original) (raw)
. 2003 Dec 19;278(51):51630-7.
doi: 10.1074/jbc.M307095200. Epub 2003 Oct 7.
Affiliations
- PMID: 14532289
- DOI: 10.1074/jbc.M307095200
Free article
Heterodimerization of substance P and mu-opioid receptors regulates receptor trafficking and resensitization
Manuela Pfeiffer et al. J Biol Chem. 2003.
Free article
Abstract
The micro-opioid receptor (MOR1) and the substance P receptor (NK1) coexist and functionally interact in nociceptive brain regions; however, a molecular basis for this interaction has not been established. Using coimmunoprecipitation and bioluminescence resonance energy transfer (BRET), we show that MOR1 and NK1 can form heterodimers in HEK 293 cells coexpressing the two receptors. Although NK1-MOR1 heterodimerization did not substantially change the ligand binding and signaling properties of these receptors, it dramatically altered their internalization and resensitization profile. Exposure of the NK1-MOR1 heterodimer to the MOR1-selective ligand [D-Ala2,Me-Phe4,Gly5-ol]enkephalin (DAMGO) promoted cross-phosphorylation and cointernalization of the NK1 receptor. Conversely, exposure of the NK1-MOR1 heterodimer to the NK1-selective ligand substance P (SP) promoted cross-phosphorylation and cointernalization of the MOR1 receptor. In cells expressing MOR1 alone, beta-arrestin directs the receptors to clathrin-coated pits, but does not internalize with the receptor. In cells expressing NK1 alone, beta-arrestin internalizes with the receptor into endosomes. Interestingly, in cells coexpressing MOR1 and NK1 both DAMGO and SP induced the recruitment of beta-arrestin to the plasma membrane and cointernalization of NK1-MOR1 heterodimers with beta-arrestin into the same endosomal compartment. Consequently, resensitization of MOR1-dependent receptor functions was severely delayed in coexpressing cells as compared with cells expressing MOR1 alone. Together, our findings indicate that MOR1 by virtue of its physical interaction with NK1 is sequestered via an endocytotic pathway with delayed recycling and resensitization kinetics.
Similar articles
- Heterodimerization of somatostatin and opioid receptors cross-modulates phosphorylation, internalization, and desensitization.
Pfeiffer M, Koch T, Schröder H, Laugsch M, Höllt V, Schulz S. Pfeiffer M, et al. J Biol Chem. 2002 May 31;277(22):19762-72. doi: 10.1074/jbc.M110373200. Epub 2002 Mar 14. J Biol Chem. 2002. PMID: 11896051 - ADP-ribosylation factor-dependent phospholipase D2 activation is required for agonist-induced mu-opioid receptor endocytosis.
Koch T, Brandenburg LO, Schulz S, Liang Y, Klein J, Hollt V. Koch T, et al. J Biol Chem. 2003 Mar 14;278(11):9979-85. doi: 10.1074/jbc.M206709200. Epub 2003 Jan 7. J Biol Chem. 2003. PMID: 12519790 - Carboxyl-terminal splicing of the rat mu opioid receptor modulates agonist-mediated internalization and receptor resensitization.
Koch T, Schulz S, Schröder H, Wolf R, Raulf E, Höllt V. Koch T, et al. J Biol Chem. 1998 May 29;273(22):13652-7. doi: 10.1074/jbc.273.22.13652. J Biol Chem. 1998. PMID: 9593704 - Replacement of threonine 394 by alanine facilitates internalization and resensitization of the rat mu opioid receptor.
Wolf R, Koch T, Schulz S, Klutzny M, Schröder H, Raulf E, Bühling F, Höllt V. Wolf R, et al. Mol Pharmacol. 1999 Feb;55(2):263-8. doi: 10.1124/mol.55.2.263. Mol Pharmacol. 1999. PMID: 9927617 - Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons.
Dang VC, Christie MJ. Dang VC, et al. Br J Pharmacol. 2012 Mar;165(6):1704-1716. doi: 10.1111/j.1476-5381.2011.01482.x. Br J Pharmacol. 2012. PMID: 21564086 Free PMC article. Review.
Cited by
- Search for the "ideal analgesic" in pain treatment by engineering the mu-opioid receptor.
Tao PL, Law PY, Loh HH. Tao PL, et al. IUBMB Life. 2010 Feb;62(2):103-11. doi: 10.1002/iub.292. IUBMB Life. 2010. PMID: 20039371 Free PMC article. Review. - p38 MAPK and beta-arrestin 2 mediate functional interactions between endogenous micro-opioid and alpha2A-adrenergic receptors in neurons.
Tan M, Walwyn WM, Evans CJ, Xie CW. Tan M, et al. J Biol Chem. 2009 Mar 6;284(10):6270-81. doi: 10.1074/jbc.M806742200. Epub 2009 Jan 6. J Biol Chem. 2009. PMID: 19126537 Free PMC article. - Modulation of GABA transport by adenosine A1R-A2AR heteromers, which are coupled to both Gs- and G(i/o)-proteins.
Cristóvão-Ferreira S, Navarro G, Brugarolas M, Pérez-Capote K, Vaz SH, Fattorini G, Conti F, Lluis C, Ribeiro JA, McCormick PJ, Casadó V, Franco R, Sebastião AM. Cristóvão-Ferreira S, et al. J Neurosci. 2011 Nov 2;31(44):15629-39. doi: 10.1523/JNEUROSCI.2526-11.2011. J Neurosci. 2011. PMID: 22049406 Free PMC article. Retracted. - Revolution in GPCR signalling: opioid receptor heteromers as novel therapeutic targets: IUPHAR review 10.
Fujita W, Gomes I, Devi LA. Fujita W, et al. Br J Pharmacol. 2014 Sep;171(18):4155-76. doi: 10.1111/bph.12798. Br J Pharmacol. 2014. PMID: 24916280 Free PMC article. Review. - Opioid-receptor-heteromer-specific trafficking and pharmacology.
van Rijn RM, Whistler JL, Waldhoer M. van Rijn RM, et al. Curr Opin Pharmacol. 2010 Feb;10(1):73-9. doi: 10.1016/j.coph.2009.09.007. Epub 2009 Oct 19. Curr Opin Pharmacol. 2010. PMID: 19846340 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous